Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-124 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0636 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783 |
filingDate |
2002-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f433a9efcf558ecca2906a3a660a619 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa83321216a1eb76ff3a982ccac63f23 |
publicationDate |
2003-10-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2003194395-A1 |
titleOfInvention |
Th1 cell adoptive immunotherapy |
abstract |
Methods for consistently producing a pure population of activated, polyclonal, Th1 memory cells for use in adoptive immunotherapy without the use of any exogenous cytokines and without significant subject-to-subject variation are provided. The resulting cells obtain a surface phenotype that enables their trafficking to tumors and other sites of inflammation upon infusion. The cells can be reinfused into the a subject to enhance the cellular immune response and/or switch the predominant immune response from Th2-dominated to a Th1-dominated immune response. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012045423-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003235908-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006121005-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002019048-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10301590-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9528088-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009137017-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002119568-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8617884-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11760973-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005118173-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103068973-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7977095-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6867041-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003119185-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108245673-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10385315-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6797514-B2 |
priorityDate |
2001-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |